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In the last 5 years there have been major advances in the under-
standing of malignant lymphoma and other lymphoproliferative
diseases, particularly at the molecular level. Along with this,
diagnostic precision has increased dramatically and many distinct
clinico-pathological entities can now be readily identified. The
revised European American Lymphoma (REAL) classification,
shortly to be superseded by the WHO classification of lymphoma,
incorporates many of these new findings and forms the basis of
this book which, according to the authors, is intended for those
undertaking higher specialist training in haematology, pathology
or oncology, those in established posts who require a review of the
subject, and research workers, specialist nurses and laboratory
staff involved in the fields of haematopathology. The book divides
broadly into two parts, the first of which covers principles of
diagnosis and treatment and the second of which deals with
specific entities within the lymphoproliferative disorders.
Part 1 comprises easy to read and accessible accounts of the
structure of the lymphoid system, laboratory methods for diag-
nosis and classification and then moves on to cover staging and
imaging and principles of therapy of lymphoproliferative dis-
orders, finishing with a chapter on classification. The chapters on
lymphoid structure and laboratory methods are particularly strong
providing excellent summaries of the subjects. The laboratory
methods included in Chapter 2 include conventional morphology,
cytochemistry and immunohistochemistry but move on to give
clear and well-illustrated accounts of other methodologies
including flow cytometry, Southern blotting, polymerase chain
reaction, in situ hybridization, etc. These chapters are particularly
useful and will prove especially valuable to clinicians who wish to
have a basic grasp of modern diagnostic techniques in lymphoma
pathology.
The chapter on staging is nicely divided by anatomical site and
gives a reasonably up to date and concise account of available
radiological techniques, although is possibly a little misleading in
places. For example, the role of routine chest radiography is some-
what understated, particularly for Hodgkin’s disease, in which, at
present, assessment of mediastinal masses on chest X-ray remains
a major factor in therapeutic decisions. The role of magnetic
resonance imaging as a means of assessing disease viability in
residual masses and staging the bone marrow is overstated since
there have been conflicting reports of the value of this technique
and, unfortunately, the chapter presents relatively little data on the
use of Gallium scanning and none on the use of PET scanning,
which is an emerging technique in lymphomas.
The chapter on principles of therapy begins with an excellent
description of apoptopic pathways and the way in which currently
available treatments can modify these. It is a welcome change
from the standard account of the action of cytotoxic drugs and
radiotherapy etc.
Section 2 of the book covers the specific lymphoproliferative
disorders, divided up roughly along the lines of the REAL classifi-
cation, although the authors acknowledge that it was not possible
to adhere strictly to this. Nevertheless, this provides a novel
approach to the accounts of these various lymphoma entities.
Each of these chapters take a roughly similar approach to the
groups of diseases being discussed. Each provides a thorough
description of the diagnosis, pathology and molecular pathology
of the disorders followed by, in most cases, a concise but relatively
brief account of treatment. This section of the book is particularly
strong in its coverage of pathology, diagnosis and underlying
molecular mechanisms, and is heavily biased in this direction.
Accounts of management of the diseases are relatively brief and
will be inadequate for those who wish to gain an insight into some
of the complexities of clinical management. For example, the
chapter on Hodgkin’s disease provides an elegantly written
account of the various sub-types of Hodgkin’s disease, including
lymphocyte predominant nodular Hodgkin’s disease and then the
various types of classical Hodgkin’s with an extensive description
of their pathology, the nature of the Reed–Sternberg cell, etc.
However, treatment issues in Hodgkin’s disease are condensed
into only approximately three pages and fail to convey the
complexity of the treatment decisions in this disease, the balance
between disease control and long-term toxicity and the many
ongoing clinical trials. Similarly, in this chapter and the chapter
on the peripheral B-cell lymphoproliferative disorders, the role
of high-dose therapy in stem cell transplantation is somewhat
understated.
The general presentation of the book is very attractive. It is
broken into small sections interspersed with useful ‘take home
messages’ in bold type which stand out clearly and emphasize
many important points. There are a very large number of line
drawings, which are particularly useful. All of the photomicro-
graphs, however, are half-tones. Presumably this is in order to
keep the cost of the book down, but it is obviously very difficult to
convey modern immunohistochemical techniques in half-tone
illustrations.
A relatively large number of computerized tomography scans
are reproduced in the book and, unfortunately, many of these are of
rather low quality. A small number of colour illustrations are
included, although it is not entirely clear why the authors chose
these particular entities as colour plates.
Each section of the book ends with a list of key references.
There are significant omissions from these. For example, the
chapter on peripheral B-cell diseases does not contain a reference
to the International Prognostic Index, to the South West Oncology
Group randomized trial in aggressive non-Hodgkin’s lymphoma,
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Article no. bjoc.1998.0402or to the Parma protocol, all of which are landmark papers in this
entity. Similarly, the Hodgkin’s disease chapter does not acknow-
ledge the contribution of the EORTC Lymphoma Trials Group
studies, or include a reference to the CALGB randomized trial
which established ABVD as standard therapy in this disease.
Despite these criticisms, many clinicians and others involved in
the treatment of haematological malignancy will find this book
extremely useful. It will be of particular use to those wishing to
gain a clearer insight into the diagnosis and pathogenesis of
lymphoproliferative disorders, but will probably be inadequate for
those wishing to have a full account of the clinical issues
surrounding these conditions.
JW Sweetenham
Medical Oncology Unit,
University of Southampton,
Southampton SO16 6YD
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Within a week of receiving this book for review, it had become one
of my first-line reference texts and I recommended that we buy
more copies for our Department. Kenneth Offit has used his wide
experience in the field of cancer genetics to produce a broad-based
text covering all aspects of cancer genetics. Not only is the scien-
tific basis of cancer genetics explained in detail, but the practical
problems of using it in the clinic setting explored in chapters
looking at genetic testing and the management of patients with
cancer, reproductive counselling for cancer patients and their fami-
lies and finally the psychological, ethical and legal issues in cancer
risk counselling. The part of genetics I have always found the most
challenging has been the complex risk calculations that one has to
embark on when you are looking at syndromes with variable age of
onset and non-penetrance, such as HNPCC and BRCA1 and
BRCA2. I found the chapter on quantitative methods in cancer risk
assessment one of the clearest written I have ever read.
There are two long chapters covering the everyday management
of specific cancer predisposition syndromes. One covers the
common hereditary cancers (breast, ovarian, colon and prostate),
and the other the commoner cancer predisposition syndromes. I
found the information given was up to date and accurate. Reading
the text as a geneticist there were useful discussions about patient
details that we are not so familiar with such as the significance of
the pathology of different types of tumours.
The book ends with a series of appendices. The only criticism
I have of the book is Appendix A, which gives a Table of
inherited disorders that may predispose to cancer listed by organ
system. The idea behind this is useful in that if you look up the
malignancy that you are interested in, it then gives you the organ
system in which you will find syndromes with these tumours. I
have used this several times in the clinic setting and found the
searching laborious. I have also found the information given on a
particular condition to be different depending on what body
system it is listed in. In at least one case (Neurofibromatosis type
1) the information given is conflicting. This is, however, a minor
criticism. Appendix B gives a list of laboratories in the USA which
offer the various cancer genetic tests and their approximate price.
It also provides very useful Internet resources. The final appendix
gives Tables of familial risk for breast, ovarian and colon cancer.
The text is indispersed with relevant case histories which helps
to reinforce the points made in the general text.
Who should buy this book? I really have no hesitation in
advising that all those involved in cancer genetic counselling on a
regular basis should purchase a copy. For those who are less often
involved, but want a reference text to occasionally dip into, I
would be tempted to delay purchase of a new cancer genetic text-
book until the second edition of Hodgson and Maher (A Practical
Guide to Human Cancer Genetics) becomes available. Comparing
Offit’s book with the first edition of Hodson and Maher’s book is
not really fair as this came out in 1993 and so is now quite out of
date. A new edition is promised in the near future. As Offit wrote
his book based on experience in an American cancer centre, the
advantage of the Hodgson and Maher text would be that it is
written with an up to date perspective on cancer genetic coun-
selling in the UK.
SM Huson,
Department of Clinical Genetics,
Oxford Radcliffe Hospital, 
The Churchill Hospital,
Old Road, Headington,
Oxford OX3 7LJ
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